to $9. It is churning, and that is okay." St . Jude Medical (NYSE: STJ ): " STJ is my preferred pick in that category ..... MDT ), Covidien (NYSE: COV ): Cramer prefers St . Jude Medical to these stocks. Weatherford (NYSE: WFT
ICD, Boston racked up 4% year-over-year ICD growth--the strongest seen in 12 quarters. Although peers St . Jude Medical and Medtronic have both launched leadless pacemakers, Boston still offers the only leadless ICD. While Boston
St . Jude Medical 's (NYSE: STJ ) Flexibility Ablation Catheter achieves CE Mark clearance in Europe. The product has a flexible tip that reduces complications
July 16 (Reuters) - Heart device maker St . Jude Medical Inc said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not
St . Jude Medical Inc. (NYSE: STJ ) Q2 2014 Results Earnings Conference ..... Presentation Operator Welcome to the St . Jude Medical Second Quarter 2014 Earnings Conference ..... and Chief Executive Officer of St . Jude Medical . Before we begin, let me remind
July 16 (Reuters) - Heart device maker St . Jude Medical Inc reported a quarterly net profit that more than doubled as expenses fell.
St . Jude Medical (NYSE: STJ ) Q2 results: Total Revenues: $1,448M (+3.2%); ICD: $462M (+1.8%); Pacemakers: $271M (+2.7%); AF
St . Jude Medical (NYSE: STJ ): Q2 EPS of $1.02 beats by $0.02 . Revenue of $1.45B (+3.6% Y/Y) beats by $10M . Press Release Post your comment!
St . Jude Medical posted solid second-quarter performance ..... estimate in place. We were heartened to see St . Jude 's sales of implantable cardioverter defibrillators ..... recently declined in the low single digits. St . Jude 's recent acquisition of Cardiomems
St . Jude Medical ( STJ -0.8% ) enters into a definitive agreement to acquire privately ..... conclude the transaction in late Q3. NeuroTherm will add $10M - 15M to STJ 's top-line sales in 2014. NeuroTherm's technology utilizes radiofrequency